Chuck Triano | SVP, IR |
Albert Bourla | Chairman and CEO |
Frank D’Amelio | CFO |
Mikael Dolsten | President, Worldwide Research and Development |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
John Young | Chief Business Officer |
David Risinger | Morgan Stanley |
Chris Schott | JP Morgan |
Umer Raffat | Evercore ISI |
Terence Flynn | Goldman Sachs |
Randall Stanicky | RBC Capital Markets |
Tim Anderson | Wolfe Research |
Louise Chen | Cantor |
Steve Scala | Cowen |
Andrew Baum | Citi |
Vamil Divan | Mizuho Securities |
Navin Jacob | UBS |
Carter Gould | Barclays |
Good day, everyone, and welcome to Pfizer’s First Quarter 2020 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.